北大医药董事长被逮捕

Group 1 - The chairman and president of Peking University Pharmaceutical Co., Ltd. (referred to as Peking University Pharmaceutical) has been arrested for criminal charges, impacting the company's leadership and operations [1] - Peking University Pharmaceutical is primarily engaged in the research, production, and sales of chemical drug formulations, as well as pharmaceutical distribution and medical services [1] - The company's product range includes formulations for anti-infection, analgesics, psychiatric disorders, digestive systems, and cardiovascular issues [1] Group 2 - The largest shareholder of Peking University Pharmaceutical is Southwest Synthetic Pharmaceutical Group, holding a direct stake of 22.22% [1] - The chairman, Xu Xiren, indirectly holds 132,455,475 shares of Peking University Pharmaceutical, representing 22.22% of the total share capital, making him the actual controller of the company [1] - Xu Xiren was appointed as chairman in April 2025 after the resignation of the previous chairman, Qi Zixin [1]